.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prof. Dr. Johannes Oldenburg

Bonn/ DE

Uniklinikum Bonn

eingeladene Redner

20.09.2023
14:30 – 14:45 15 Min. 0 Min.
Vortrag
VS-7-1
Neue Richtlinien Hämotherapie 2023

Vortrag

21.09.2023
08:45 – 09:00 12 Min. 3 Min.
Freier Vortrag
VS-12-2
Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec: results from GENEr8-1
Hemostaseology

Weitere Beteiligungen

21.09.2023
08:30 – 08:45 12 Min. 3 Min.
Freier Vortrag (Reinhold-Eckstein-Investigator-Award)
VS-12-1
Assessment of cellular and plasmatic determinants of the APC response to thrombin in factor V Leiden carriers using an endothelial cell-based ex vivo model
Hemostaseology
21.09.2023
08:45 – 09:00 12 Min. 3 Min.
Freier Vortrag
VS-12-2
Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec: results from GENEr8-1
Hemostaseology
21.09.2023
17:45 – 17:48 2 Min. 1 Min.
ePoster
PS-2-26
Structural characterization of B domain and full-length of coagulation factor VIII
Hemostaseology
22.09.2023
13:50 – 14:00 8 Min. 2 Min.
Freier Vortrag
VS-22-3
Enhanced NK-cell cytotoxicity by combining genome editing and RIG-I activation
Immunotherapy